Israel-headquartered biofuel developer Evogene's revenues for fiscal 2009 nearly tripled to $10m at the end of the year, compared to $3.4m for the same period in 2008.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Find out who else is a subscriber »
Become a Premium SubscriberIf you are already a NewNet subscriber please log in below.
Legals & Terms of Use • Privacy Policy
NewNet is a trading name of New Energy World Network Ltd, registered in England (No. 06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © New Energy World Network (NewNet) 2008-2012